Spiros Fourlanos

3.4k total citations
91 papers, 2.0k citations indexed

About

Spiros Fourlanos is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Spiros Fourlanos has authored 91 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Endocrinology, Diabetes and Metabolism, 39 papers in Genetics and 33 papers in Surgery. Recurrent topics in Spiros Fourlanos's work include Diabetes Management and Research (60 papers), Diabetes and associated disorders (39 papers) and Pancreatic function and diabetes (28 papers). Spiros Fourlanos is often cited by papers focused on Diabetes Management and Research (60 papers), Diabetes and associated disorders (39 papers) and Pancreatic function and diabetes (28 papers). Spiros Fourlanos collaborates with scholars based in Australia, United Kingdom and Ireland. Spiros Fourlanos's co-authors include Peter G. Colman, Leonard C. Harrison, Parth Narendran, Christopher J. Yates, John M. Wentworth, Olov Rolandsson, Jerry P. Palmer, Francesco Dotta, Carla J. Greenbaum and S. Cohney and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Spiros Fourlanos

80 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Spiros Fourlanos Australia 23 1.3k 1.0k 945 195 183 91 2.0k
Joachim Beige Germany 26 674 0.5× 245 0.2× 375 0.4× 433 2.2× 228 1.2× 112 2.4k
Gareth Dunseath United Kingdom 23 1.0k 0.8× 316 0.3× 462 0.5× 287 1.5× 307 1.7× 77 1.8k
Wen Xu China 20 754 0.6× 268 0.3× 463 0.5× 347 1.8× 153 0.8× 116 1.4k
R Gunnarsson Sweden 26 841 0.6× 583 0.6× 1.0k 1.1× 228 1.2× 235 1.3× 86 1.8k
Milla Rosengård‐Bärlund Finland 20 970 0.7× 373 0.4× 328 0.3× 157 0.8× 184 1.0× 31 1.8k
Sofia Dahlqvist Sweden 16 2.1k 1.6× 941 0.9× 1.0k 1.1× 263 1.3× 171 0.9× 25 2.6k
Kim Pettersson-Fernholm Finland 20 769 0.6× 396 0.4× 323 0.3× 123 0.6× 117 0.6× 28 1.4k
P. J. Bingley United Kingdom 24 1.8k 1.4× 1.5k 1.5× 1.2k 1.3× 212 1.1× 113 0.6× 37 2.5k
Ernesto Maddaloni Italy 26 953 0.7× 643 0.6× 616 0.7× 403 2.1× 310 1.7× 95 2.1k
Pauli Karhapää Finland 26 853 0.7× 180 0.2× 433 0.5× 328 1.7× 477 2.6× 38 2.1k

Countries citing papers authored by Spiros Fourlanos

Since Specialization
Citations

This map shows the geographic impact of Spiros Fourlanos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spiros Fourlanos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spiros Fourlanos more than expected).

Fields of papers citing papers by Spiros Fourlanos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spiros Fourlanos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spiros Fourlanos. The network helps show where Spiros Fourlanos may publish in the future.

Co-authorship network of co-authors of Spiros Fourlanos

This figure shows the co-authorship network connecting the top 25 collaborators of Spiros Fourlanos. A scholar is included among the top collaborators of Spiros Fourlanos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spiros Fourlanos. Spiros Fourlanos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barmanray, Rahul, et al.. (2025). Early Electronic Specialist-led Diabetes Care Improves Postdischarge Glycemia: The STOIC-D Surgery Follow-up Cohort. The Journal of Clinical Endocrinology & Metabolism. 111(2). e375–e381.
2.
Barmanray, Rahul, et al.. (2024). Improved macronutrient composition of meals delivered to people with diabetes in hospital: a pre–post, mixed‐methods observational study. Journal of Human Nutrition and Dietetics. 38(1). e13375–e13375.
3.
Fourlanos, Spiros, et al.. (2024). Diabetic ketoacidosis as first presentation of undiagnosed pancreatic cancer in an octogenarian. Endocrinology Diabetes and Metabolism Case Reports. 2024(4).
4.
Kiburg, Katerina, et al.. (2024). Treatment Satisfaction With Omnipod DASH in Adults With Type 1 Diabetes: A Nonblinded 1:1 Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 109(8). 1984–1995.
5.
Symons, R. C. Andrew, et al.. (2024). The relationship between ON–OFF function and OCT structural and angiographic parameters in early diabetic retinal disease. Ophthalmic and Physiological Optics. 45(1). 77–88. 2 indexed citations
6.
Trawley, Steven, Katerina Kiburg, N. M. Harrison, et al.. (2024). “You can hide it if you want to, you can let it be seen if you want to”: A qualitative study of the lived experiences of Australian adults with type 1 diabetes using the Omnipod DASH® system. Diabetes Research and Clinical Practice. 208. 111123–111123.
7.
Kwon, Hye Jin, Steven Trawley, Sara Vogrin, et al.. (2024). Driving-Related Glucose Patterns Among Older Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. 26(5). 335–340. 2 indexed citations
8.
Trawley, Steven, Hye Jin Kwon, Sara Vogrin, et al.. (2024). Automated Insulin Delivery Effects During Driving Among Older Adults with Type 1 Diabetes in a Randomized Trial. Diabetes Technology & Therapeutics. 27(2). 134–138.
9.
10.
Trawley, Steven, et al.. (2023). Real‐world lived experience of older adults with type 1 diabetes after an automated insulin delivery trial. Diabetic Medicine. 41(4). e15264–e15264. 2 indexed citations
11.
Fourlanos, Spiros, et al.. (2023). Automated insulin delivery among adults with type 1 diabetes for up to 2 years: a real‐world, multicentre study. Internal Medicine Journal. 54(1). 121–128. 7 indexed citations
12.
Chakrabarti, Anindita, Steven Trawley, Sara Vogrin, et al.. (2022). Closed-Loop Insulin Delivery Effects on Glycemia During Sleep and Sleep Quality in Older Adults with Type 1 Diabetes: Results from the ORACL Trial. Diabetes Technology & Therapeutics. 24(9). 666–671. 14 indexed citations
13.
Trawley, Steven, Glenn M. Ward, Spiros Fourlanos, et al.. (2022). Lived experience of older adults with type 1 diabetes using closed‐loop automated insulin delivery in a randomised trial. Diabetic Medicine. 40(4). e15020–e15020. 16 indexed citations
14.
Chakrabarti, Anindita, et al.. (2022). Exercise habits and glucose management among older adults with type 1 diabetes using insulin pumps. Acta Diabetologica. 59(6). 865–868. 1 indexed citations
15.
Wang, Ray, et al.. (2021). End-of-Life Care Requires Caution with Use of Continuous Glucose Monitoring. Journal of Palliative Medicine. 25(3). 516–518. 2 indexed citations
16.
McAuley, Sybil A., Steven Trawley, Sara Vogrin, et al.. (2021). Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. Diabetes Care. 45(2). 381–390. 57 indexed citations
17.
Ng, Ashley, et al.. (2021). Prevalence of disordered eating in adults with type 1 diabetes in an Australian metropolitan hospital. Health & Social Care in the Community. 30(4). e974–e980. 10 indexed citations
18.
McAuley, Sybil A., Sara Vogrin, Steven Trawley, et al.. (2021). OLDER ADULTS WITH TYPE 1 DIABETES: GLUCOSE OUTCOMES WITH TECHNOLOGY AND EDUCATION. Diabetes Technology & Therapeutics. 23. 1 indexed citations
19.
Nolan, Brendan J., et al.. (2020). Beware Ketoacidosis with SGLT2 Inhibitors in Latent Autoimmune Diabetes of the Adult. The American Journal of Medicine. 133(8). e422–e424. 2 indexed citations
20.
Fourlanos, Spiros, et al.. (2003). Fasting insulin, fasting glucose and insulin resistance is increased in pre-clinical Type 1 diabetes.. Diabetologia. 46. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joachim Beige Breakdown of academic impact, for papers by Gareth Dunseath Breakdown of academic impact, for papers by Wen Xu Breakdown of academic impact, for papers by R Gunnarsson Breakdown of academic impact, for papers by Milla Rosengård‐Bärlund Breakdown of academic impact, for papers by Sofia Dahlqvist Breakdown of academic impact, for papers by Kim Pettersson-Fernholm Breakdown of academic impact, for papers by P. J. Bingley Breakdown of academic impact, for papers by Ernesto Maddaloni Breakdown of academic impact, for papers by Pauli Karhapää
Rankless by CCL
2026